AUPO693397A0 - Carotenoid formulation - Google Patents

Carotenoid formulation

Info

Publication number
AUPO693397A0
AUPO693397A0 AUPO6933A AUPO693397A AUPO693397A0 AU PO693397 A0 AUPO693397 A0 AU PO693397A0 AU PO6933 A AUPO6933 A AU PO6933A AU PO693397 A AUPO693397 A AU PO693397A AU PO693397 A0 AUPO693397 A0 AU PO693397A0
Authority
AU
Australia
Prior art keywords
carotenoid formulation
carotenoid
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO6933A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Betatene Ltd
Original Assignee
Betatene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Betatene Ltd filed Critical Betatene Ltd
Priority to AUPO6933A priority Critical patent/AUPO693397A0/en
Publication of AUPO693397A0 publication Critical patent/AUPO693397A0/en
Priority to ZA984230A priority patent/ZA984230B/en
Priority to CN98807515A priority patent/CN1272059A/en
Priority to IL13298998A priority patent/IL132989A0/en
Priority to PCT/US1998/010356 priority patent/WO1998052561A1/en
Priority to AU76903/98A priority patent/AU736104B2/en
Priority to EP98924820A priority patent/EP1005339A4/en
Priority to JP55060398A priority patent/JP2001527573A/en
Priority to US10/659,475 priority patent/US20040191297A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AUPO6933A 1997-05-22 1997-05-22 Carotenoid formulation Abandoned AUPO693397A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AUPO6933A AUPO693397A0 (en) 1997-05-22 1997-05-22 Carotenoid formulation
ZA984230A ZA984230B (en) 1997-05-22 1998-05-19 Carotenoid formulation
CN98807515A CN1272059A (en) 1997-05-22 1998-05-20 Carotenoid formulation
IL13298998A IL132989A0 (en) 1997-05-22 1998-05-20 Carotenoid formulation
PCT/US1998/010356 WO1998052561A1 (en) 1997-05-22 1998-05-20 Carotenoid formulation
AU76903/98A AU736104B2 (en) 1997-05-22 1998-05-20 Carotenoid formulation
EP98924820A EP1005339A4 (en) 1997-05-22 1998-05-20 Carotenoid formulation
JP55060398A JP2001527573A (en) 1997-05-22 1998-05-20 Carotenoid preparation
US10/659,475 US20040191297A1 (en) 1997-05-22 2003-09-10 Carotenoid formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO6933A AUPO693397A0 (en) 1997-05-22 1997-05-22 Carotenoid formulation

Publications (1)

Publication Number Publication Date
AUPO693397A0 true AUPO693397A0 (en) 1997-06-12

Family

ID=3801224

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO6933A Abandoned AUPO693397A0 (en) 1997-05-22 1997-05-22 Carotenoid formulation

Country Status (7)

Country Link
EP (1) EP1005339A4 (en)
JP (1) JP2001527573A (en)
CN (1) CN1272059A (en)
AU (1) AUPO693397A0 (en)
IL (1) IL132989A0 (en)
WO (1) WO1998052561A1 (en)
ZA (1) ZA984230B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141039A (en) 2001-01-23 2006-10-31 Lycored Natural Prod Ind Ltd Anti-atherosclerosis composition containing carotenoids and use in the preparation of medicaments for inhibiting ldl oxidation
IL146449A0 (en) * 2001-11-12 2002-07-25 Lycored Natural Prod Ind Ltd Method and pharmaceutical preparations for reducing the activity of cells
BRPI0509148B8 (en) 2004-03-22 2021-05-25 Abbott Products Gmbh oral pharmaceutical compositions of products containing lipase, in particular pancreatin containing surfactants, their uses and respective manufacturing processes
EP1618800A1 (en) * 2004-07-24 2006-01-25 Cognis IP Management GmbH Active compositions comprising lycopene, cytidin and fatty acids
JP5140586B2 (en) 2005-07-29 2013-02-06 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング Production of sterile pancreatin powder
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2403363B1 (en) * 2009-03-05 2012-12-26 Basf Se Formulation of astaxanthin derivatives and use thereof ii
TWI491414B (en) * 2011-05-25 2015-07-11 Taiwan Textile Res Inst Skin caring product with indicating function and method of using the same
CN107260675B (en) * 2013-12-11 2018-12-18 健永生技股份有限公司 The medical composition of carotenoid
US9889084B2 (en) * 2014-01-10 2018-02-13 Valicor, Inc. Compositions of cosmetic, personal care and skin care products derived from lipid feedstocks and methods to produce the same
CN112569212A (en) * 2019-09-30 2021-03-30 富士胶片株式会社 Oily composition, process for producing the same, and soft capsule

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7812896L (en) * 1978-01-13 1979-07-14 Hoffmann La Roche CLEANING PREPARATION
US4316917A (en) * 1980-04-21 1982-02-23 Hoffman-La Roche Inc. Stable carotenoid solutions
US4343823A (en) * 1981-04-03 1982-08-10 Kalsec, Inc. Liquid seasoning compositions IV
JPH08120187A (en) * 1994-10-26 1996-05-14 Lion Corp Aqueous composition containing carotenoid and beverage containing carotenoid
JP2750281B2 (en) * 1995-06-15 1998-05-13 睦憲 藤原 Hypercholesterolemia treatment

Also Published As

Publication number Publication date
JP2001527573A (en) 2001-12-25
EP1005339A4 (en) 2004-06-09
WO1998052561A1 (en) 1998-11-26
IL132989A0 (en) 2001-03-19
CN1272059A (en) 2000-11-01
ZA984230B (en) 1999-04-20
EP1005339A1 (en) 2000-06-07

Similar Documents

Publication Publication Date Title
AU8551198A (en) Agrochemical formulation
AUPO889497A0 (en) An applicator
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AUPO742497A0 (en) An applicator
AU7606198A (en) Coloring composition
AU5272198A (en) EMP-charge-eliminator
AUPO693397A0 (en) Carotenoid formulation
AU4117497A (en) Micropolarimeter
AU6998698A (en) Dioxacycloalkan-8-one
AU9256898A (en) Methoximinomethyloxadiazines used as pesticides
AU6185898A (en) Clavaspirins
AU6847598A (en) Colour legalisation
AU7761998A (en) Korrosionsschutzanstrichstoff
AU8214598A (en) 3-benzylpiperidine
AU8079198A (en) Pesticide formulation
AU1649700A (en) Novel formulation
AU9183798A (en) Catamaran - bicycle - kayak
AU4469997A (en) Heregulin-gamma
AU5391798A (en) Thiamacrolides
AU8991998A (en) Renovative pipeliner